GROWTH & SUSTAINABILITY
GROWTH & SUSTAINABILITY
Sustainability is Deep-Rooted In All Our Decision Making
We always strive to do more in order to positively impact our patients consumers, employees, communities as well as our shareholders. We firmly believed that doing business with a conscience is integral in order to sustain our business success.
LATEST
11 AUGUST 2023
Pharmaniaga Berhad (Pharmaniaga) is embarking on an extensive business restructuring exercise
that includes implementing rigorous fiscal discipline initiatives across its operations as part of the
Group’s comprehensive recovery plan.
26 JULY 2023
Pharmaniaga Berhad (Pharmaniaga) and CSPC Pharmaceutical Group Limited (CSPC) of China
today forged a partnership on the research and development, manufacturing, and commercialisation
of innovative pharmaceutical and biopharmaceutical products.
21 JULY 2023
Pharmaniaga Berhad (Pharmaniaga) today has successfully completed its 10% first private share
placement exercise and a second tranche of 10% is expected to be taken up by Armed Forces Fund
Board (LTAT), subject to shareholders’ approval.
12 JUNE 2023
Pharmaniaga Berhad (Pharmaniaga) outlines a strategic plan to address the challenges presented by its Practice Note 17 (PN17) status, with a strong focus on financial recalibration and a resolute commitment
to overcome obstacles. The Group charts a path towards a resilient recovery and rapid …
18 MAY 2023
The recent Practice Note 17 (PN17) status did not deter Pharmaniaga Berhad (Pharmaniaga) from demonstrating resilience and strategic agility in navigating challenging market conditions as it registered
Profit After Taxation and Zakat (PAT) of RM2.8 million in first quarter financial period ended …
21 APRIL 2023
We refer to the article entitled “Pharmaniaga Concession Renewal Decision Major Setback On
Health Reforms” posted on CodeBlue’s official website on 19 April 2023, and also published by several
media organisations.